Preclinical Development supports researchers developing stem cell-based and genetic therapies, funding candidate optimization, preclinical studies, and trial startup to advance toward first-in-human trials.
CLIN2 Awards: Funding Opportunity for Clinical Trials supports organizations conducting stem cell-based and genetic therapy trials to address serious unmet medical needs and advance therapies toward approval.
CIRM’s Discovery Stage Research program funds collaborative, innovative basic research to advance breakthroughs in regenerative medicine and stem cell biology, focusing on foundational science and early-stage discoveries.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.
Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.
Commercialization Project Development Teams (PDTs) support faculty investigators with project funding, expertise, and collaboration to move MedTech devices and drug development toward commercialization.